Loading...
Reach Banner
Keywords
Last name
Institution

Cecil Pace-Asciak

TitleSenior Scientist Emeritus
InstitutionThe Hospital for Sick Children
DepartmentTranslational Medicine
Address555 University Avenue
Toronto ON M5G 1X8
Phone416-813-1500
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Khan MA, Pace-Asciak C, Al-Hassan JM, Afzal M, Liu YF, Oommen S, Paul BM, Nair D, Palaniyar N. Furanoid F-Acid F6 Uniquely Induces NETosis Compared to C16 and C18 Fatty Acids in Human Neutrophils. Biomolecules. 2018 Nov 13; 8(4). PMID: 30428625.
      View in: PubMed
    2. Douda DN, Grasemann H, Pace-Asciak C, Palaniyar N. A lipid mediator hepoxilin A3 is a natural inducer of neutrophil extracellular traps in human neutrophils. Mediators Inflamm. 2015; 2015:520871. PMID: 25784781; PMCID: PMC4345265.
    3. Pace-Asciak CR. Pathophysiology of the hepoxilins. Biochim Biophys Acta. 2015 Apr; 1851(4):383-96. PMID: 25240838.
      View in: PubMed
    4. Masood A, Yi M, Lau M, Belcastro R, Li J, Kantores C, Pace-Asciak CR, Jankov RP, Tanswell AK. Cyclooxygenase-2 inhibition partially protects against 60% O2 -mediated lung injury in neonatal rats. Pediatr Pulmonol. 2014 Oct; 49(10):991-1002. PMID: 24273102.
      View in: PubMed
    5. Bosco N, Brahmbhatt V, Oliveira M, Martin FP, Lichti P, Raymond F, Mansourian R, Metairon S, Pace-Asciak C, Bastic Schmid V, Rezzi S, Haller D, Benyacoub J. Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis. 2013 May 31; 12:81. PMID: 23725086; PMCID: PMC3691874.
    6. Pace-Asciak CR, Li X, Reynaud D, Qiao N, Demin P, Abdelhaleem M. Alterations in eicosanoid levels during U937 bcl-xL tumour growth suppression and recovery in NU/NU mice in vivo-Involvement of phospholipase A2. Prostaglandins Other Lipid Mediat. 2013 Dec; 107:43-7. PMID: 23548786.
      View in: PubMed
    7. Brahmbhatt V, Oliveira M, Briand M, Perrisseau G, Bastic Schmid V, Destaillats F, Pace-Asciak C, Benyacoub J, Bosco N. Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress. J Nutr Biochem. 2013 Jan; 24(1):104-11. PMID: 22819560.
      View in: PubMed
    8. Pace-Asciak CR. Hepoxilins in cancer and inflammation--use of hepoxilin antagonists. Cancer Metastasis Rev. 2011 Dec; 30(3-4):493-506. PMID: 22005952.
      View in: PubMed
    9. Pouteau E, Aprikian O, Grenot C, Reynaud D, Pace-Asciak C, Cuilleron CY, Castañeda-Gutiérrez E, Moulin J, Pescia G, Beysen C, Turner S, Macé K. A low alpha-linolenic intake during early life increases adiposity in the adult guinea pig. Nutr Metab (Lond). 2010 Jan 29; 7:8. PMID: 20205840; PMCID: PMC2825514.
    10. Pace-Asciak CR. The hepoxilins and some analogues: a review of their biology. Br J Pharmacol. 2009 Oct; 158(4):972-81. PMID: 19422397; PMCID: PMC2785520.
    11. Steels JD, Estey MP, Froese CD, Reynaud D, Pace-Asciak C, Trimble WS. Sept12 is a component of the mammalian sperm tail annulus. Cell Motil Cytoskeleton. 2007 Oct; 64(10):794-807. PMID: 17685441.
      View in: PubMed
    12. Aprikian O, Reynaud D, Pace-Asciak C, Leone P, Blancher F, Monnard I, Darimont C, Macé K. Neonatal dietary supplementation of arachidonic acid increases prostaglandin levels in adipose tissue but does not promote fat mass development in guinea pigs. Am J Physiol Regul Integr Comp Physiol. 2007 Nov; 293(5):R2006-12. PMID: 17761509.
      View in: PubMed
    13. Qiao N, Reynaud D, Abdelhaleem M, Pace-Asciak CR. Hepoxilin analogs, PBT-3 and PBT-4, cause apoptosis of Gleevec-resistant K562 cells in vitro. In Vivo. 2007 Mar-Apr; 21(2):267-71. PMID: 17436575.
      View in: PubMed
    14. Huang YW, Surka MC, Reynaud D, Pace-Asciak C, Trimble WS. GTP binding and hydrolysis kinetics of human septin 2. FEBS J. 2006 Jul; 273(14):3248-60. PMID: 16857012.
      View in: PubMed
    15. Hanson J, Reynaud D, Qiao N, Devel P, Moray AL, Renard JF, Kelley LP, Winum JY, Montero JL, Kinsella BT, Pirotte B, Pace-Asciak CR, Dogné JM. Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptor. J Med Chem. 2006 Jun 15; 49(12):3701-9. PMID: 16759113.
      View in: PubMed
    16. Copland IB, Reynaud D, Pace-Asciak C, Post M. Mechanotransduction of stretch-induced prostanoid release by fetal lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006 Sep; 291(3):L487-95. PMID: 16603590.
      View in: PubMed
    17. Dogné JM, Hanson J, de Leval X, Pratico D, Pace-Asciak CR, Drion P, Pirotte B, Ruan KH. From the design to the clinical application of thromboxane modulators. Curr Pharm Des. 2006; 12(8):903-23. PMID: 16533159.
      View in: PubMed
    18. Pace-Asciak CR, Li X, Qiao N, Reynaud D, Demin P, Abdelhaleem M. Hepoxilin analogs, potential new therapeutics in disease. Curr Pharm Des. 2006; 12(8):963-9. PMID: 16533163.
      View in: PubMed
    19. Duggan M, McNamara PJ, Engelberts D, Pace-Asciak C, Babyn P, Post M, Kavanagh BP. Oxygen attenuates atelectasis-induced injury in the in vivo rat lung. Anesthesiology. 2005 Sep; 103(3):522-31. PMID: 16129977.
      View in: PubMed
    20. Li X, Qiao N, Reynaud D, Abdelhaleem M, Pace-Asciak CR. PBT-3, a hepoxilin stable analog, causes long term inhibition of growth of K562 solid tumours in vivo. Biochem Biophys Res Commun. 2005 Dec 09; 338(1):158-60. PMID: 16102726.
      View in: PubMed
    21. Pace-Asciak CR. Novel eicosanoid pathways: the discovery of prostacyclin/6-keto prostaglandin F1alpha and the hepoxilins. Mol Neurobiol. 2005 Aug; 32(1):19-26. PMID: 16077180.
      View in: PubMed
    22. Li X, Qiao N, Reynaud D, Abdelhaleem M, Pace-Asciak CR. The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumours in vivo in nude mice. In Vivo. 2005 Jan-Feb; 19(1):185-9. PMID: 15796172.
      View in: PubMed
    23. Hanson J, Rolin S, Reynaud D, Qiao N, Kelley LP, Reid HM, Valentin F, Tippins J, Kinsella BT, Masereel B, Pace-Asciak C, Pirotte B, Dogné JM. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. J Pharmacol Exp Ther. 2005 Apr; 313(1):293-301. PMID: 15626721.
      View in: PubMed
    24. Qiao N, Reynaud D, Demin P, Halushka PV, Pace-Asciak CR. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells. J Pharmacol Exp Ther. 2003 Dec; 307(3):1142-7. PMID: 14560042.
      View in: PubMed
    25. Qiao N, Lam J, Reynaud D, Abdelhaleem M, Pace-Asciak CR. The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cells. Anticancer Res. 2003 Sep-Oct; 23(5A):3617-22. PMID: 14666657.
      View in: PubMed
    26. Vogan CL, Maskrey BH, Taylor GW, Henry S, Pace-Asciak CR, Clare AS, Rowley AF. Hepoxilins and trioxilins in barnacles: an analysis of their potential roles in egg hatching and larval settlement. J Exp Biol. 2003 Sep; 206(Pt 18):3219-26. PMID: 12909703.
      View in: PubMed
    27. Belik J, Jankov RP, Pan J, Yi M, Pace-Asciak CR, Tanswell AK. Effect of 8-isoprostaglandin F2alpha on the newborn rat pulmonary arterial muscle and endothelium. J Appl Physiol (1985). 2003 Nov; 95(5):1979-85. PMID: 12857766.
      View in: PubMed
    28. Reynaud D, Clark D, Qiao N, Rand ML, Pace-Asciak CR. The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100. Thromb Res. 2003; 112(4):245-8. PMID: 14987919.
      View in: PubMed
    29. Amer RK, Pace-Asciak CR, Mills LR. A lipoxygenase product, hepoxilin A(3), enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro. Neuroscience. 2003; 116(4):935-46. PMID: 12617935.
      View in: PubMed
    30. Jankov RP, Luo X, Demin P, Aslam R, Hannam V, Tanswell AK, Pace-Asciak CR. Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse. J Pharmacol Exp Ther. 2002 May; 301(2):435-40. PMID: 11961041.
      View in: PubMed
    31. Pace-Asciak CR, Reynaud D, Demin P, Aslam R, Sun A. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition. J Pharmacol Exp Ther. 2002 May; 301(2):618-24. PMID: 11961065.
      View in: PubMed
    32. Reynaud D, Hinek A, Pace-Asciak CR. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP. FEBS Lett. 2002 Mar 27; 515(1-3):58-60. PMID: 11943194.
      View in: PubMed
    33. Reynaud D, Sun A, Demin P, Pace-Asciak CR. Novel platelet antiaggregating substances. Biochem Biophys Res Commun. 2001 Jun 15; 284(3):580-2. PMID: 11396939.
      View in: PubMed
    34. Chen P, Policova Z, Pace-Asciak CR, Neumann AW. Study of binding of 12(S)-hydroxy-5(Z),8(Z),10(E), 14(Z)-eicosatetraenoic acid to bovine serum albumin using dynamic surface tension measurements. J Pharm Sci. 1999 Dec; 88(12):1293-8. PMID: 10585225.
      View in: PubMed
    35. Pace-Asciak CR, Demin PM, Estrada M, Liu G. Hepoxilins raise circulating insulin levels in vivo. FEBS Lett. 1999 Nov 19; 461(3):165-8. PMID: 10567690.
      View in: PubMed
    36. Wang MM, Demin PM, Pace-Asciak CR. Stereoselective actions of hepoxilins A3 and B3 and their cyclopropane analogs (HxdeltaA3 and HxdeltaB3) on bradykinin and PAF-evoked potentiation of vascular leakage in rat skin. Gen Pharmacol. 1999 Nov; 33(5):377-82. PMID: 10553878.
      View in: PubMed
    37. Reynaud D, Ali M, Demin P, Pace-Asciak CR. Formation of 14,15-hepoxilins of the A(3) and B(3) series through a 15-lipoxygenase and hydroperoxide isomerase present in garlic roots. J Biol Chem. 1999 Oct 01; 274(40):28213-8. PMID: 10497175.
      View in: PubMed
    38. Milone SD, Pace-Asciak CR, Reynaud D, Azevedo ER, Newton GE, Parker JD. Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance. J Cardiovasc Pharmacol. 1999 May; 33(5):685-90. PMID: 10226853.
      View in: PubMed
    39. Reynaud D, Demin PM, Sutherland M, Nigam S, Pace-Asciak CR. Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3. FEBS Lett. 1999 Mar 12; 446(2-3):236-8. PMID: 10100848.
      View in: PubMed
    40. Wang MM, Reynaud D, Pace-Asciak CR. In vivo stimulation of 12(S)-lipoxygenase in the rat skin by bradykinin and platelet activating factor: formation of 12(S)-HETE and hepoxilins, and actions on vascular permeability. Biochim Biophys Acta. 1999 Jan 04; 1436(3):354-62. PMID: 9989266.
      View in: PubMed
    41. Pace-Asciak CR, Reynaud D, Demin P, Nigam S. The hepoxilins. A review. Adv Exp Med Biol. 1999; 447:123-32. PMID: 10086189.
      View in: PubMed
    42. Pace-Asciak CR, Reynaud D, Rounova O, Demin P, Pivnitsky KK. Hepoxilin A3 is metabolized into its omega-hydroxy metabolite by human neutrophils. Adv Exp Med Biol. 1999; 469:535-8. PMID: 10667379.
      View in: PubMed
    43. Al-Hassan JM, Ali M, Thomson M, Pace-Asciak CR. Detection of 8-epi prostaglandin F2alpha in an extract of epidermal secretion of the catfish from the Arabian Gulf. Prostaglandins Leukot Essent Fatty Acids. 1998 Nov; 59(5):325-8. PMID: 9888207.
      View in: PubMed
    44. Reynaud D, Rounova O, Demin PM, Pivnitsky KK, Pace-Asciak CR. Hepoxilin A3 is oxidized by human neutrophils into its omega-hydroxy metabolite by an activity independent of LTB4 omega-hydroxylase. Biochim Biophys Acta. 1997 Oct 18; 1348(3):287-98. PMID: 9366245.
      View in: PubMed
    45. Reynaud D, Pace-Asciak CR. Docosahexaenoic acid causes accumulation of free arachidonic acid in rat pineal gland and hippocampus to form hepoxilins from both substrates. Biochim Biophys Acta. 1997 Jun 23; 1346(3):305-16. PMID: 9219915.
      View in: PubMed
    46. Mills L, Reynaud D, Pace-Asciak CR. Hepoxilin-evoked intracellular reorganization of calcium in human neutrophils: a confocal microscopy study. Exp Cell Res. 1997 Feb 01; 230(2):337-41. PMID: 9024792.
      View in: PubMed
    47. Reynaud D, Pace-Asciak CR. 12-HETE and 12-HPETE potently stimulate intracellular release of calcium in intact human neutrophils. Prostaglandins Leukot Essent Fatty Acids. 1997 Jan; 56(1):9-12. PMID: 9044430.
      View in: PubMed
    48. Pace-Asciak CR, Reynaud D, Laneuville O, Grinstein S, Nigam S. Hepoxilin A3 inhibits agonist-evoked rise in free intracellular calcium in human neutrophils. Adv Exp Med Biol. 1997; 400A:375-80. PMID: 9547579.
      View in: PubMed
    49. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta. 1996 Mar 15; 246(1-2):163-82. PMID: 8814965.
      View in: PubMed
    50. Goldberg DM, Garovic-Kocic V, Diamandis EP, Pace-Asciak CR. Wine: does the colour count? Clin Chim Acta. 1996 Mar 15; 246(1-2):183-93. PMID: 8814966.
      View in: PubMed
    51. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 1996 Mar; 27(2):363-6. PMID: 8919657.
      View in: PubMed
    52. Reynaud D, Demin P, Pace-Asciak CR. Hepoxilin A3-specific binding in human neutrophils. Biochem J. 1996 Jan 15; 313 ( Pt 2):537-41. PMID: 8573089; PMCID: PMC1216940.
    53. Wang MM, Demin PM, Pace-Asciak CR. Epimer-specific actions of hepoxilins A3 and B3 on PAF- and bradykinin-evoked vascular permeability in the rat skin in vivo. Adv Exp Med Biol. 1996; 416:239-41. PMID: 9131155.
      View in: PubMed
    54. Demin PM, Reynaud D, Pace-Asciak CR. Chemical synthesis and actions of 11,12-thiirano-hepoxilin A3. J Lipid Mediat Cell Signal. 1996 Jan; 13(1):63-72. PMID: 8998598.
      View in: PubMed
    55. Demin P, Reynaud D, Pace-Asciak CR. High-performance liquid chromatographic separation of fluorescent esters of hepoxilin enantiomers on a chiral stationary phase. J Chromatogr B Biomed Appl. 1995 Oct 20; 672(2):282-9. PMID: 8581135.
      View in: PubMed
    56. Pace-Asciak CR, Reynaud D, Demin P. Mechanistic aspects of hepoxilin biosynthesis. J Lipid Mediat Cell Signal. 1995 Oct; 12(2-3):307-11. PMID: 8777574.
      View in: PubMed
    57. Demin P, Reynaud D, Pace-Asciak CR. Extractive derivatization of the 12-lipoxygenase products, hepoxilins, and related compounds into fluorescent anthryl esters for their complete high-performance liquid chromatography profiling in biological systems. Anal Biochem. 1995 Apr 10; 226(2):252-5. PMID: 7793626.
      View in: PubMed
    58. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta. 1995 Mar 31; 235(2):207-19. PMID: 7554275.
      View in: PubMed
    59. Reynaud D, Demin P, Pace-Asciak CR. Hepoxilin binding in human neutrophils. Biochem Biophys Res Commun. 1995 Feb 06; 207(1):191-4. PMID: 7857263.
      View in: PubMed
    60. Pace-Asciak CR, Reynaud D, Demin PM. Hepoxilins: a review on their enzymatic formation, metabolism and chemical synthesis. Lipids. 1995 Feb; 30(2):107-14. PMID: 7769965.
      View in: PubMed
    61. Reynaud D, Demin PM, Pace-Asciak CR. Coupling of hepoxilin A3-specific binding with calcium-mobilizing actions in human neutrophils. Agents Actions Suppl. 1995; 45:291-6. PMID: 7717192.
      View in: PubMed
    62. Reynaud D, Demin PM, Pace-Asciak CR. Enzymatic formation of hepoxilin A3. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:183-5. PMID: 7732831.
      View in: PubMed
    63. Pace-Asciak CR. Hepoxilins: a review on their cellular actions. Biochim Biophys Acta. 1994 Nov 17; 1215(1-2):1-8. PMID: 7947989.
      View in: PubMed
    64. Reynaud D, Demin P, Pace-Asciak CR. Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxyeicosatetraenoic acid (HPETE), but not (12R)-HPETE. J Biol Chem. 1994 Sep 30; 269(39):23976-80. PMID: 7929046.
      View in: PubMed
    65. Carlen PL, Gurevich N, Zhang L, Wu PH, Reynaud D, Pace-Asciak CR. Formation and electrophysiological actions of the arachidonic acid metabolites, hepoxilins, at nanomolar concentrations in rat hippocampal slices. Neuroscience. 1994 Feb; 58(3):493-502. PMID: 7909586.
      View in: PubMed
    66. Reynaud D, Delton I, Gharib A, Sarda N, Lagarde M, Pace-Asciak CR. Formation, metabolism, and action of hepoxilin A3 in the rat pineal gland. J Neurochem. 1994 Jan; 62(1):126-33. PMID: 8263512.
      View in: PubMed
    67. Pace-Asciak CR, Reynaud D, Demin P. Enzymatic formation of hepoxilins A3 and B3. Biochem Biophys Res Commun. 1993 Dec 15; 197(2):869-73. PMID: 8267626.
      View in: PubMed
    68. Laneuville O, Reynaud D, Grinstein S, Nigam S, Pace-Asciak CR. Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4. Biochem J. 1993 Oct 15; 295 ( Pt 2):393-7. PMID: 8240236; PMCID: PMC1134894.
    69. Reynaud D, Thickitt CP, Pace-Asciak CR. Facile preparation and structural determination of monohydroxy derivatives of docosahexaenoic acid (HDoHE) by alpha-tocopherol-directed autoxidation. Anal Biochem. 1993 Oct; 214(1):165-70. PMID: 8250220.
      View in: PubMed
    70. Pace-Asciak CR. Hepoxilins. Gen Pharmacol. 1993 Jul; 24(4):805-10. PMID: 8224734.
      View in: PubMed
    71. Margalit A, Sofer Y, Grossman S, Reynaud D, Pace-Asciak CR, Livne AA. Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets. Proc Natl Acad Sci U S A. 1993 Apr 01; 90(7):2589-92. PMID: 8464865; PMCID: PMC46140.
    72. Laneuville O, Couture R, Pace-Asciak CR. Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins. Br J Pharmacol. 1992 Nov; 107(3):808-12. PMID: 1335339; PMCID: PMC1907779.
    73. Moscarello MA, Pang H, Pace-Asciak CR, Wood DD. The N terminus of human myelin basic protein consists of C2, C4, C6, and C8 alkyl carboxylic acids. J Biol Chem. 1992 May 15; 267(14):9779-82. PMID: 1374408.
      View in: PubMed
    74. Laneuville O, Couture R, Pace-Asciak CR. Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action. Br J Pharmacol. 1992 Feb; 105(2):297-304. PMID: 1559126; PMCID: PMC1908669.
    75. Lin Z, Laneuville O, Pace-Asciak CR. Hepoxilin A3 induces heat shock protein (HSP72) expression in human neutrophils. Biochem Biophys Res Commun. 1991 Aug 30; 179(1):52-6. PMID: 1883378.
      View in: PubMed
    76. Laneuville O, Corey EJ, Couture R, Pace-Asciak CR. Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate. Biochim Biophys Acta. 1991 Jun 19; 1084(1):60-8. PMID: 1675872.
      View in: PubMed
    77. Pace-Asciak CR, Nigam S. Hepoxilins modulate second messenger systems in the human neutrophil. Adv Exp Med Biol. 1991; 314:133-9. PMID: 1818483.
      View in: PubMed
    78. Pace-Asciak CR, Laneuville O, Gurevich N, Wu P, Carlen PL, Corey EJ. Formation of a glutathionyl-conjugate of hepoxilin A3 and its action in rat brain. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21B:731-4. PMID: 1825403.
      View in: PubMed
    79. Laneuville O, Corey EJ, Couture R, Pace-Asciak CR. Hepoxilin A3 increases vascular permeability in the rat skin. Eicosanoids. 1991; 4(2):95-7. PMID: 1910867.
      View in: PubMed
    80. Pace-Asciak CR, Wong L, Corey EJ. Hepoxilin A3 blocks the release of norepinephrine from rat hippocampal slices. Biochem Biophys Res Commun. 1990 Dec 31; 173(3):949-53. PMID: 2268355.
      View in: PubMed
    81. Laneuville O, Chang M, Reddy CC, Corey EJ, Pace-Asciak CR. Isozyme specificity in the conversion of hepoxilin A3 (HxA3) into a glutathionyl hepoxilin (HxA3-C) by the Yb2 subunit of rat liver glutathione S-transferase. J Biol Chem. 1990 Dec 15; 265(35):21415-8. PMID: 2254303.
      View in: PubMed
    82. Nigam S, Nodes S, Cichon G, Corey EJ, Pace-Asciak CR. Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils. Biochem Biophys Res Commun. 1990 Sep 28; 171(3):944-8. PMID: 2171511.
      View in: PubMed
    83. Pace-Asciak CR, Laneuville O, Su WG, Corey EJ, Gurevich N, Wu P, Carlen PL. A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system. Proc Natl Acad Sci U S A. 1990 Apr; 87(8):3037-41. PMID: 2326264; PMCID: PMC53829.
    84. Dho S, Grinstein S, Corey EJ, Su WG, Pace-Asciak CR. Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils. Biochem J. 1990 Feb 15; 266(1):63-8. PMID: 2106877; PMCID: PMC1131096.
    85. Pace-Asciak CR, Laneuville O, Chang M, Reddy CC, Su WG, Corey EJ. New products in the hepoxilin pathway: isolation of 11-glutathionyl hepoxilin A3 through reaction of hepoxilin A3 with glutathione S-transferase. Biochem Biophys Res Commun. 1989 Sep 29; 163(3):1230-4. PMID: 2675836.
      View in: PubMed
    86. Carlen PL, Gurevich N, Wu PH, Su WG, Corey EJ, Pace-Asciak CR. Actions of arachidonic acid and hepoxilin A3 on mammalian hippocampal CA1 neurons. Brain Res. 1989 Sep 11; 497(1):171-6. PMID: 2507088.
      View in: PubMed
    87. Pace-Asciak CR, Lee WS. Purification of hepoxilin epoxide hydrolase from rat liver. J Biol Chem. 1989 Jun 05; 264(16):9310-3. PMID: 2722835.
      View in: PubMed
    88. Pace-Asciak CR. One-step rapid extractive methylation of plasma nonesterified fatty acids for gas chromatographic analysis. J Lipid Res. 1989 Mar; 30(3):451-4. PMID: 2723549.
      View in: PubMed
    89. Pace-Asciak CR, Asotra S. Biosynthesis, catabolism, and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radic Biol Med. 1989; 7(4):409-33. PMID: 2514125.
      View in: PubMed
    90. Pace-Asciak CR. Mass spectra of prostaglandins and related products. Adv Prostaglandin Thromboxane Leukot Res. 1989; 18:1-565. PMID: 2521759.
      View in: PubMed
    91. Pace-Asciak CR, Asotra S, Pellerin L, Wolfe LS, Corey EJ, Wu P, Gurevich N, Carlen PL. Brain hepoxilins: formation and action. Adv Prostaglandin Thromboxane Leukot Res. 1989; 19:141-7. PMID: 2526459.
      View in: PubMed
    92. Pieroni JP, Dray F, Pace-Asciak CR, McGiff JC. Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit. J Pharmacol Exp Ther. 1988 Oct; 247(1):63-8. PMID: 3139870.
      View in: PubMed
    93. Pace-Asciak CR, Martin JM, Lee SP. Appearance of prostaglandins, thromboxane B2, and hepoxilin A3 in the circulation of the normal and diabetic (BB) rat after arachidonic acid administration--correlation with plasma insulin. Biochem Cell Biol. 1988 Aug; 66(8):901-9. PMID: 3143376.
      View in: PubMed
    94. Pace-Asciak CR. Formation and metabolism of hepoxilin A3 by the rat brain. Biochem Biophys Res Commun. 1988 Feb 29; 151(1):493-8. PMID: 3348791.
      View in: PubMed
    95. Pace-Asciak CR, Lee SP, Martin JM. In vivo formation of hepoxilin A3 in the rat. Biochem Biophys Res Commun. 1987 Sep 30; 147(3):881-4. PMID: 3117060.
      View in: PubMed
    96. Pace-Asciak CR. Prostaglandins and related products profiled by GC/MS with negative-ion chemical-ionization detection. Clin Invest Med. 1987 May; 10(3):117-20. PMID: 3113796.
      View in: PubMed
    97. Pace-Asciak CR, Klein J, Spielberg SP. Metabolism of leukotriene A4 into C4 by human platelets. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17A:127-33. PMID: 2821752.
      View in: PubMed
    98. Pace-Asciak CR, Klein J, Spielberg SP. Human genetic defect in leukotriene C4 synthesis. Biochem Biophys Res Commun. 1986 Nov 14; 140(3):857-60. PMID: 3022737.
      View in: PubMed
    99. Pace-Asciak CR, Klein J, Spielberg SP. Metabolism of leukotriene A4 into C4 by human platelets. Biochim Biophys Acta. 1986 Jun 11; 877(1):68-74. PMID: 2872925.
      View in: PubMed
    100. Pace-Asciak CR. Formation of hepoxilin A4, B4 and the corresponding trioxilins from 12(S)-hydroperoxy-5,8,10,14,17-icosapentaenoic acid. Prostaglandins Leukot Med. 1986 Apr; 22(1):1-9. PMID: 3012585.
      View in: PubMed
    101. Pace-Asciak CR, Klein J, Speilberg SP. Epoxide hydratase assay in human platelets using hepoxilin A3 as a lipid substrate. Biochim Biophys Acta. 1986 Feb 12; 875(2):406-9. PMID: 3942774.
      View in: PubMed
    102. Pace-Asciak CR, Martin JM, Corey EJ. Hepoxilins, potential endogenous mediators of insulin release. Prog Lipid Res. 1986; 25(1-4):625-8. PMID: 3321096.
      View in: PubMed
    103. Pace-Asciak CR, Klein J, Lombard S, Torchia J, Rokach J. Catabolism of leukotriene A4 into B4, C4, and D4 by rat liver subcellular fractions. Biochim Biophys Acta. 1985 Aug 22; 836(1):153-6. PMID: 2992598.
      View in: PubMed
    104. Pace-Asciak CR, Martin JM, Corey EJ, Su WG. Endogenous release of hepoxilin A3 from isolated perifused pancreatic islets of Langerhans. Biochem Biophys Res Commun. 1985 Apr 30; 128(2):942-6. PMID: 3888220.
      View in: PubMed
    105. Pace-Asciak CR. Profiling of prostaglandins and related products by GC/MS with negative-ion chemical-ionization detection. Adv Prostaglandin Thromboxane Leukot Res. 1985; 15:39-43. PMID: 2936128.
      View in: PubMed
    106. Derewlany LO, Pace-Asciak CR, Radde IC. Hepoxilin A, hydroxyepoxide metabolite of arachidonic acid, stimulates transport of 45Ca across the guinea pig visceral yolk sac. Can J Physiol Pharmacol. 1984 Dec; 62(12):1466-9. PMID: 6442210.
      View in: PubMed
    107. Pace-Asciak CR, Domazet Z. 9-Hydroxyprostaglandin dehydrogenase in rat kidney cortex converts prostaglandin I2 into 15-keto-13,14-dihydro 6-ketoprostaglandin E1. Biochim Biophys Acta. 1984 Nov 14; 796(2):129-35. PMID: 6388642.
      View in: PubMed
    108. Pace-Asciak CR, Martin JM. Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets. Prostaglandins Leukot Med. 1984 Nov; 16(2):173-80. PMID: 6396652.
      View in: PubMed
    109. Pace-Asciak CR, Micallef S. Gas chromatographic-mass spectrometric profiling with negative-ion chemical ionization detection of prostaglandins and their 15-keto and 15-keto-13,14-dihydro catabolites in rat blood. J Chromatogr. 1984 Oct 12; 310(2):233-42. PMID: 6511843.
      View in: PubMed
    110. Pace-Asciak CR, Micallef S. Catabolism of 6-keto prostaglandin E1 by rat kidney homogenates. Can J Biochem Cell Biol. 1984 Aug; 62(8):709-14. PMID: 6548656.
      View in: PubMed
    111. Pace-Asciak CR. Arachidonic acid epoxides. Demonstration through [18O]oxygen studies of an intramolecular transfer of the terminal hydroxyl group of (12S)-hydroperoxyeicosa-5,8,10,14-tetraenoic acid to form hydroxyepoxides. J Biol Chem. 1984 Jul 10; 259(13):8332-7. PMID: 6429142.
      View in: PubMed
    112. Pace-Asciak CR. Hemoglobin- and hemin-catalyzed transformation of 12L-hydroperoxy-5,8,10,14-eicosatetraenoic acid. Biochim Biophys Acta. 1984 May 11; 793(3):485-8. PMID: 6712984.
      View in: PubMed
    113. Demerson CA, Humber LG, Abraham NA, Schilling G, Martel RR, Pace-Asciak C. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. J Med Chem. 1983 Dec; 26(12):1778-80. PMID: 6227748.
      View in: PubMed
    114. Pace-Asciak CR, Granström E, Samuelsson B. Arachidonic acid epoxides. Isolation and structure of two hydroxy epoxide intermediates in the formation of 8,11,12- and 10,11,12-trihydroxyeicosatrienoic acids. J Biol Chem. 1983 Jun 10; 258(11):6835-40. PMID: 6406490.
      View in: PubMed
    115. Pace-Asciak CR, Rangaraj G. Release of prostaglandins from intact fetal lamb ductus arteriosus. Can J Biochem Cell Biol. 1983 May; 61(5):240-7. PMID: 6411303.
      View in: PubMed
    116. Rosenthal A, Pace-Asciak CR. Potent vasoconstriction of the isolated perfused rat kidney by leukotrienes C4 and D4. Can J Physiol Pharmacol. 1983 Apr; 61(4):325-8. PMID: 6860996.
      View in: PubMed
    117. Pace-Asciak CR, Rangaraj G. Application of prostaglandin-profiling techniques to study the release of prostaglandins from the fetal lamb ductus arteriosus. Biochim Biophys Acta. 1983 Feb 07; 750(2):330-3. PMID: 6860685.
      View in: PubMed
    118. Yokoyama C, Mizuno K, Mitachi H, Yoshimoto T, Yamamoto S, Pace-Asciak CR. Partial purification and characterization of arachidonate 12-lipoxygenase from rat lung. Biochim Biophys Acta. 1983 Feb 07; 750(2):237-43. PMID: 6407525.
      View in: PubMed
    119. Pace-Asciak CR, Mizuno K, Yamamoto S, Granström E, Samuelsson B. Oxygenation of arachidonic acid into 8,11,12- and 10,11,12-trihydroxyeicosatrienoic acid by rat lung. Adv Prostaglandin Thromboxane Leukot Res. 1983; 11:133-9. PMID: 6221515.
      View in: PubMed
    120. Pace-Asciak CR, Mizuno K, Yamamoto S. Resolution by DEAE-cellulose chromatography of the enzymatic steps in the transformation of arachidonic acid into 8, 11, 12- and 10, 11, 12-trihydroxy-eicosatrienoic acid by the rat lung. Prostaglandins. 1983 Jan; 25(1):79-84. PMID: 6405454.
      View in: PubMed
    121. Pace-Asciak CR, Mizuno K, Yamamoto S. The enzymatic conversion of arachidonic acid into 8,11,12-trihydroxyeicosatrienoic acid. Resolution of rat lung enzyme into two active fractions. Biochim Biophys Acta. 1982 Jul 20; 712(1):142-5. PMID: 6810942.
      View in: PubMed
    122. Edwards NS, Pace-Asciak CR. A time study comparing the appearance of catabolites of 9 alpha, 11 alpha, 15(S)-trihydroxyprosta-5,13-dienoic acid in blood and urine during constant intravenous infusion of tritiated 9 alpha, 11 alpha, 15(S)-trihydroxyprosta-5,13-dienoic acid in the rat. Isolation of a new circulating catabolite. J Biol Chem. 1982 Jun 10; 257(11):6339-42. PMID: 7042711.
      View in: PubMed
    123. Edwards NS, Pace-Asciak CR. Identification of a 'urinary-type' metabolite of prostaglandin F2 alpha in the rat circulation. Biochim Biophys Acta. 1982 May 13; 711(2):369-71. PMID: 6953981.
      View in: PubMed
    124. Ferdinandi ES, Cayen MN, Pace-Asciak C. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats. J Pharmacol Exp Ther. 1982 Feb; 220(2):417-26. PMID: 6460096.
      View in: PubMed
    125. Pace-Asciak CR, Edwards NS. Preparation of deuterium-labeled urinary catabolites of PGF2 alpha as standards for GC-MS. Methods Enzymol. 1982; 86:552-9. PMID: 6957703.
      View in: PubMed
    126. Pace-Asciak CR, Edwards NS. Preparation of 2,3,4,5-tetranor-thromboxane B2, the major urinary catabolite of thromboxane B2 in the rat. Methods Enzymol. 1982; 86:604-7. PMID: 7132772.
      View in: PubMed
    127. Pace-Asciak CR, Mizuno K, Yamamoto S. Isolation of an enzyme system in rat lung cytosol which converts arachidonic acid into 8,11,12-trihydroxyeicosatrienoic acid. Adv Prostaglandin Thromboxane Leukot Res. 1982; 9:71-6. PMID: 6211961.
      View in: PubMed
    128. Pace-Asciak CR, Rosenthal A. Opposition of the vasopressin-induced vasoconstriction in the isolated perfused rat kidney by some prostaglandins. Prostaglandins. 1981 Oct; 22(4):567-74. PMID: 6948319.
      View in: PubMed
    129. Pace-Asciak CR, Mizuno K, Yamamoto S. Formation of 8,11,12-trihydroxyeicosatrienoic acid by a rat lung high-speed supernatant fraction. Biochim Biophys Acta. 1981 Aug 24; 665(2):352-4. PMID: 6793080.
      View in: PubMed
    130. Pace-Asciak CR, Rosenthal A. Constriction of the isolated intact rat kidney by vasopressin is strongly opposed by PGE1 and PGE2. Prog Lipid Res. 1981; 20:605-8. PMID: 6952270.
      View in: PubMed
    131. Pace-Asciak CR, Edwards NS. Age and sex dependent alterations in PGF2 alpha catabolism in the rat in vivo. Prog Lipid Res. 1981; 20:747-50. PMID: 6952271.
      View in: PubMed
    132. Pace-Asciak CR, Carrara MC, Levine L. PGI2 is not a circulating vasodepressor hormone. Prog Lipid Res. 1981; 20:113-6. PMID: 7043476.
      View in: PubMed
    133. Pace-Asciak CR, Carrara MC, Levine L, Nicolaou KC. PGI2-specific antibodies administered in vivo suggest against a role for endogenous PGI2 as a circulating vasodepressor hormone in the normotensive and spontaneously hypertensive rat. Prostaglandins. 1980 Dec; 20(6):1053-60. PMID: 7010446.
      View in: PubMed
    134. Pace-Asciak CR, Edwards NS. Tetranor thromboxane B2 is the principal urinary catabolite formed after i.v. infusion of thromboxane B2 in the rat. Biochem Biophys Res Commun. 1980 Nov 17; 97(1):81-6. PMID: 7458943.
      View in: PubMed
    135. Pace-Asciak CR, Carrara MC, Levine L. Antibodies to 5,6-dihydroprostaglandin I2 trap endogenously produced prostaglandin I2 in the rat circulation. Biochim Biophys Acta. 1980 Nov 07; 620(2):186-92. PMID: 7002219.
      View in: PubMed
    136. Pace-Asciak CR, Edwards NS. Distinct age-related changes in the urinary catabolic profile of prostaglandin F2 alpha in the rat. J Biol Chem. 1980 Jul 10; 255(13):6106-10. PMID: 7391007.
      View in: PubMed
    137. Pace-Asciak CR, Edwards NS, Carrara MC. Age-related differences in the urinary excretion of prostaglandin F2 alpha catabolites in the rat. Experientia. 1980 Jun 15; 36(6):635-7. PMID: 6252035.
      View in: PubMed
    138. Pace-Asciak CR. Developmental aspects of the prostaglandin biosynthetic and catabolic systems. Semin Perinatol. 1980 Jan; 4(1):15-21. PMID: 6770467.
      View in: PubMed
    139. Pace-Asciak CR. Prostacyclin and hypertension. Mater Med Pol. 1980; 12(3):181-6. PMID: 7019589.
      View in: PubMed
    140. Pace-Asciak CR, Carrara MC. Ontogeny of aortic PGI2 formation in the developing spontaneously hypertensive rat--correlation with elevations in blood pressure. Adv Prostaglandin Thromboxane Res. 1980; 7:797-801. PMID: 6989206.
      View in: PubMed
    141. Pace-Asciak CR, Carrara MC. Reduction in dietary vitamin E prevents onset of hypertension in developing spontaneously hypertensive rats. Experientia. 1979 Dec 15; 35(12):1561-2. PMID: 520453.
      View in: PubMed
    142. Pace-Asciak CR, Carrara MC. Age-dependent increase in the formation of prostaglandin I2 by intact and homogenised aortae from the developing spontaneously hypertensive rat. Biochim Biophys Acta. 1979 Jul 27; 574(1):177-81. PMID: 383156.
      View in: PubMed
    143. Pace-Asciak CR, Rosenthal A, Domazet Z. Comparison between the in vivo rate of metabolism of prostaglandin I2 and its blood-pressure-lowering response after intravenous administration in the rat. Biochim Biophys Acta. 1979 Jul 27; 574(1):182-6. PMID: 383157.
      View in: PubMed
    144. Pace-Asciak CR, Carrara MC. Stability of authentic PGI2 during routine extraction. Clarification of the nature and sequence of products formed by the rat stomach including the origin of the ozonolysis products reported in 1971. Prostaglandins. 1978 Sep; 16(3):397-140. PMID: 364546.
      View in: PubMed
    145. Pace-Asciak CR, Carrara MC, Rangaraj G, Nicolaou KC. Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat. Prostaglandins. 1978 Jun; 15(6):1005-12. PMID: 358292.
      View in: PubMed
    146. Pace-Asciak CR, Carrara MC, Nicolaou KC. Prostaglandin I2 has more potent hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive rat. Prostaglandins. 1978 Jun; 15(6):999-1003. PMID: 358298.
      View in: PubMed
    147. Pace-Asciak CR, Rangaraj G. Prostaglandin biosynthesis and catabolism in the lamb ductus arteriosus, aorta and pulmonary artery. Biochim Biophys Acta. 1978 Apr 28; 529(1):13-20. PMID: 205256.
      View in: PubMed
    148. Pace-Asciak CR, Rangaraj G. Distribution of prostaglandin biosynthetic pathways in organs and tissues of the fetal lamb. Biochim Biophys Acta. 1978 Mar 30; 528(3):512-4. PMID: 638173.
      View in: PubMed
    149. Pace-Asciak CR. Prostaglandin biosynthesis and catabolism in several organs of developing fetal and neonatal animals. Adv Prostaglandin Thromboxane Res. 1978; 4:45-59. PMID: 645515.
      View in: PubMed
    150. Pace-Asciak CR, Carrara MC, Domazet Z. Identification of the major urinary metabolites of 6-ketoprostaglandin F1alpha (6K-PGF1alpha) in the rat. Biochem Biophys Res Commun. 1977 Sep 09; 78(1):115-21. PMID: 907663.
      View in: PubMed
    151. Wolfe LS, Pace-Asciak C. Prostaglandin research. Science. 1977 Jul 15; 197(4300):210. PMID: 17750439.
      View in: PubMed
    152. Pace-Asciak CR. Deuterium isotope dilution method for the specific measurement of 6-keto-prostaglandin F1alpha by mass fragmentography. Anal Biochem. 1977 Jul; 81(1):251-5. PMID: 332006.
      View in: PubMed
    153. Pace-Asciak CR, Nashat M. Mechanistic studies on the biosynthesis of 6-ketoprostaglandin F1alpha. Biochim Biophys Acta. 1977 Jun 22; 487(3):495-507. PMID: 884125.
      View in: PubMed
    154. Pace-Asciak CR, Domazet Z, Carrara M. Catabolism of 6-ketoprostaglandin F1alpha by the rat kidney cortex. Biochim Biophys Acta. 1977 May 25; 487(2):400-4. PMID: 861243.
      View in: PubMed
    155. Pace-Asciak CR. Oxidative biotransformations of arachidonic acid. Prostaglandins. 1977 May; 13(5):811-7. PMID: 405715.
      View in: PubMed
    156. Pace-Asciak CR. Prostaglandin biosynthesis and catabolism in the developing fetal sheep kidney. Prostaglandins. 1977 Apr; 13(4):661-8. PMID: 854576.
      View in: PubMed
    157. Pace-Asciak CR. Prostaglandin biosynthesis and catabolism in the developing fetal sheep lung. Prostaglandins. 1977 Apr; 13(4):649-60. PMID: 323930.
      View in: PubMed
    158. Pace-Asciak CR, Rangaraj G. The 6-ketoprostaglandin F1alpha pathway in the lamb ductus arteriousus. Biochim Biophys Acta. 1977 Mar 25; 486(3):583-5. PMID: 851548.
      View in: PubMed
    159. Pace-Asciak CR, Rangaraj G. Distribution of prostaglandin biosynthetic pathways in several rat tissues. Formation of 6-ketoprostaglandin F1alpha. Biochim Biophys Acta. 1977 Mar 25; 486(3):579-82. PMID: 856290.
      View in: PubMed
    160. Pace-Asciak CR. Decreased renal prostaglandin catabolism precedes onset of hypertension in the developing spontaneously hypertensive rat. Nature. 1976 Oct 07; 263(5577):510-12. PMID: 972699.
      View in: PubMed
    161. Pace-Asciak C, Nashat M. Catabolism of prostaglandin endoperoxides into prostaglandin E2 and F2 alpha by the rat brain. J Neurochem. 1976 Aug; 27(2):551-6. PMID: 965997.
      View in: PubMed
    162. Pace-Asciak C. Letter: Isolation, structure, and biosynthesis of 6-ketoprostaglandin F1 alpha in the rat stomach. J Am Chem Soc. 1976 Apr 14; 98(8):2348-9. PMID: 1254872.
      View in: PubMed
    163. Pace-Asciak C. A new prostaglandin metabolite of arachidonic acid. Formation of 6-keto-PGF1alpha by the rat stomach. Experientia. 1976 Mar 15; 32(3):291-2. PMID: 1253894.
      View in: PubMed
    164. Pace-Asciak C, Nashat M, Menon NK. Transformation of prostaglandin G2 into 6(9)-oxy-11,15-dihydroxy-prosta-7,13-dienoic acid by the rat stomach fundus. Biochim Biophys Acta. 1976 Feb 23; 424(2):323-5. PMID: 1252496.
      View in: PubMed
    165. Pace-Asciak CR. Biosynthesis and catabolism of prostaglandins during animal development. Adv Prostaglandin Thromboxane Res. 1976; 1:35-46. PMID: 998429.
      View in: PubMed
    166. Pace-Asciak C, Nashat M. Catabolism of an isolated, purified intermediate of prostaglandin biosynthesis by regions of the adult rat kidney. Biochim Biophys Acta. 1975 May 22; 388(2):243-52. PMID: 1169976.
      View in: PubMed
    167. Pace-Asciak C. Activity profiles of prostaglandin 15- and 9-hydroxydehydrogenase and 13-reductase in the developing rat kidney. J Biol Chem. 1975 Apr 25; 250(8):2795-800. PMID: 1123328.
      View in: PubMed
    168. Pace-Asciak C. Prostaglandin 9-hydroxydehydrogenase activity in the adult rat kidney. Identification, assay, pathway, and some enzyme properties. J Biol Chem. 1975 Apr 25; 250(8):2789-94. PMID: 235529.
      View in: PubMed
    169. Pace-Asciak C, Cole S. Inhibitors of prostaglandin catabolism. I. Differential sensitivity of 9-PGDH, 13-PGR and 15-PGDH to low concentrations of indomethacin. Experientia. 1975 Feb 15; 31(2):143-5. PMID: 1112337.
      View in: PubMed
    170. Pace-Asciak C, Miller D. Prostaglandins during development. II. Identification of prostaglandin 9-hydroxy dehydrogenase activity in adult rat kidney homogenates. Experientia. 1974 Jun 15; 30(6):590-2. PMID: 4837065.
      View in: PubMed
    171. Pace-Asciak C, Miller D. Prostaglandins during development. I. Age-dependent activity profiles of prostaglandin 15-hydroxydehydrogenase and 13,14-reductase in lung tissue from late prenatal, early postnatal and adult rats. Prostaglandins. 1973 Sep; 4(3):351-62. PMID: 4783569.
      View in: PubMed
    172. Gillett PG, Kinch RA, Wolfe LS, Pace-Asciak C. Induction of abortion by intraamniotic PGF2alpha: a comparison of dose schedules. Adv Biosci. 1973; 9:545-50. PMID: 4805866.
      View in: PubMed
    173. Gillett PG, Kinch RA, Wolfe LS, Pace-Asciak C. Therapeutic abortion in the second trimester by intra-amniotic prostaglandin F2 alpha . J Reprod Med. 1972 Dec; 9(6):416-9. PMID: 4648921.
      View in: PubMed
    174. Pace-Asciak C. Prostaglandin synthetase activity in the rat stomach fundus. Activation by L-norepinephrine and related compounds. Biochim Biophys Acta. 1972 Sep 07; 280(1):161-71. PMID: 5070652.
      View in: PubMed
    175. Pace-Asciak C, Wolfe LS, Gillett PG, Kinch RA. Disappearance of prostaglandin F2alpha from human amniotic fluid after intraamniotic injection. Prostaglandins. 1972 Jun; 1(6):469-77. PMID: 4660081.
      View in: PubMed
    176. Gillett PG, Kinch RA, Wolfe LS, Pace-Asciak C. Therapeutic abortion with the use of prostaglandin F 2 . A study of efficacy, tolerance, and plasma levels with intravenous administration. Am J Obstet Gynecol. 1972 Feb 01; 112(3):330-8. PMID: 5060379.
      View in: PubMed
    177. Pace-Asciak C, Wolfe LS. A novel prostaglandin derivative formed from arachidonic acid by rat stomach homogenates. Biochemistry. 1971 Sep 28; 10(20):3657-64. PMID: 5096392.
      View in: PubMed
    178. Pace-Asciak C. Polyhydroxy cyclic ethers formed from tritiated arachidonic acid by acetone powders of sheep seminal vesicles. Biochemistry. 1971 Sep 28; 10(20):3664-9. PMID: 5096393.
      View in: PubMed
    179. Pace-Asciak C, Wolfe LS. N-butylboronate derivatives of the F prostaglandins. Resolution of prostaglandins of the E and F series by gas-liquid chromatography. J Chromatogr. 1971 Mar 24; 56(1):129-33. PMID: 5550061.
      View in: PubMed
    180. Pace-Asciak C, Wolfe LS. Biosynthesis of prostaglandins E2 and F2-alpha from tritium-labelled arachidonic acid by rat stomach homogenates. Biochim Biophys Acta. 1970 Dec 15; 218(3):539-42. PMID: 5499209.
      View in: PubMed
    181. Pace-Asciak C, Wolfe LS. Inhibition of prostaglandin synthesis by oleic, linoleic and linolenic acids. Biochim Biophys Acta. 1968 Jul 01; 152(4):784-7. PMID: 5660093.
      View in: PubMed
    182. Pace-Asciak C, Just G, Blank F. Metabolites of pathogenic fungi. VI. The isolation of 5-thiomethyladenosine from Candida albicans. Can J Microbiol. 1968 Jan; 14(1):90-1. PMID: 5642010.
      View in: PubMed
    183. Coceani F, Pace-Asciak C, Volta F, Wolfe LS. Effect of nerve stimulation on prostaglandin formation and release from the rat stomach. Am J Physiol. 1967 Oct; 213(4):1056-64. PMID: 6051174.
      View in: PubMed
    Pace-Asciak's networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description